News

A new role for Casein Kinase-1 on RNF43 is identified – Study by Tadasuke Tsukiyama and IMBA – Institute of Molecular Biotechnology of the Austrian…

Read more

Valneva announced a vaccine partnership with the UK government for its inactivated COVID-19 vaccine, VLA2001.

Read more

Read more

Since 1947, the City of Vienna honours residents distinguished in a range of disciplines with the “Preis der Stadt Wien” awards for their life…

Read more

Valneva announced the signing of a new contract, lasting up to three years, with the U.S. government Department of Defense (DoD) for the supply of its…

Read more

Valneva announced the initiation of a pivotal Phase 3 clinical trial for its differentiated, single-shot chikungunya vaccine candidate VLA1553.  The…

Read more

LifeTime, which counts Jürgen Knoblich, scientific director at IMBA, as a leading member, has developed a strategy to integrate…

Read more

The IMP is one of thirteen European institutions participating in the four-year project ‘Deconstructing the evolution of metastasis’ (Evomet).

Read more

Autophagy, from the Greek for ‘self-eating’, is an essential process that isolates and recycles cellular components under conditions of stress or when…

Read more

The European Research Council (ERC) has selected Clemens Plaschka's research for funding under the Horizon 2020 Excellent Science scheme.

Read more

A team of researchers, spearheaded by the Gerlich lab at IMBA, has uncovered how cells remove unwanted components from the nucleus following mitosis.…

Read more

The research award is awarded annually by the B&C Private Foundation. With the Houska Prize, the B&C private foundation is committed to improving…

Read more

HCA|Organoid is a new EU research project that combines single-cell profiling and organoid technology to validate organoids as faithful models of…

Read more